MAPK1 and Alzheimer disease: Herein, EGCG-NPs significantly decreased the expression of ERK1/2 and p-p38 in the epidermis, indicating that EGCG-NPs regulated necroptosis after AD by oxidative stress/MAPK/inflammation pathway.